Sanofi: First-quarter 2018 Business EPS up 1.4% at CER
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Sanofi (SNY) Reports Q1 EPS of EUR1.28 (Earlier)
April 27, 2018 9:11 AM EDTSanofi (NYSE: SNY) earlier reported Q1 EPS of EUR1.28. Revenue for the quarter came in at EUR7.9 million.
2018 guidance confirmedFirst-quarter 2018 IFRS EPS was 0.81 (-82.0%) due to a gain on disposal of the Animal Health business in 2017.
For earnings history and earnings-related data on Sanofi (SNY) click here.
... More
